![](/img/cover-not-exists.png)
PCN140 IMPACT OF TUMOR RESPONSE ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH VELCADE/MELPHALAN/PREDNISONE (V-MP): RESULTS FROM THE VISTA TRIAL
J Meunier, A Regnault, D Robinson, K Rosa, JF San Miguel, H van de Velde, PG Richardson, A Cakana, R DhawanVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)74390-4
File:
PDF, 82 KB
english, 2009